Market revenue in 2023 | USD 342.6 million |
Market revenue in 2030 | USD 600.0 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 49.8% in 2023. Horizon Databook has segmented the UK interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The UK population is aging rapidly, with a higher proportion of individuals over the age of 65. This demographic shift increases the prevalence of age-related CVDs, driving the demand for interventional cardiology treatments and devices.
As per data from the British Cardiovascular Intervention Society and Research Manchester, PCI volumes in the UK decreased by 49% during the lockdown phase of the pandemic. This decline was most pronounced in PCI for stable angina, which witnessed a 66% volume reduction. Other studies showed similar declines in interventional cardiology procedures in other countries.
Furthermore, a study in the UK highlighted that PCI volumes decreased by 30% in the first few months of the pandemic. These companies are actively involved in strategic activities, such as product launches, partnerships, & acquisitions, to expand their presence and cater to the growing demand for interventional cardiology devices.
Horizon Databook provides a detailed overview of country-level data and insights on the UK interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into UK interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account